Patient characteristics
. | Baseline expression of 5′ GR promoter transcripts . | Effect of GCs on 5′ GR promoter and 3′ GR transcript levels . |
---|---|---|
N | 48 | 22 |
Sex | ||
Male | 28 | 12 |
Female | 20 | 10 |
Age | ||
1-9 y | 36 | 11 |
10 y and older | 12 | 11 |
Immunophenotype | ||
Precursor B-ALL | 36 | 9 |
T-ALL | 12 | 13 |
WBC | ||
Less than 50 × 109 | 18 | 3 |
50 × 109 or more | 30 | 19 |
In vitro prednisolone toxicity | ||
Sensitive | 24 | 12 |
Resistant | 24 | 10 |
. | Baseline expression of 5′ GR promoter transcripts . | Effect of GCs on 5′ GR promoter and 3′ GR transcript levels . |
---|---|---|
N | 48 | 22 |
Sex | ||
Male | 28 | 12 |
Female | 20 | 10 |
Age | ||
1-9 y | 36 | 11 |
10 y and older | 12 | 11 |
Immunophenotype | ||
Precursor B-ALL | 36 | 9 |
T-ALL | 12 | 13 |
WBC | ||
Less than 50 × 109 | 18 | 3 |
50 × 109 or more | 30 | 19 |
In vitro prednisolone toxicity | ||
Sensitive | 24 | 12 |
Resistant | 24 | 10 |